4DMedical Ltd
ASX:4DX
4DMedical Ltd
ASX:4DX
Price:
0.595 AUD
Market Closed
Updated:
May 5, 2024
Section:
Relative Value
The Relative Value of one
4DX
stock under the Base Case scenario is
0.479
AUD.
Compared to the current market price of 0.595 AUD,
4DMedical Ltd
is
Overvalued by 19%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
4DX
Relative Value
Base Case
0.479
AUD
Overvaluation 19%
Valuation Multiples
Multiples Across Competitors
4DX Competitors Multiples
4DMedical Ltd Competitors
4DMedical Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
4DMedical Ltd
ASX:4DX
|
232.6m AUD | 226.9 | -7.5 | -6 | -6 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.8B USD | 13.9 | 62.4 | 62.3 | 67 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.9B AUD | 81.1 | 170.1 | 117 | 117 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.8 | -349 | -184.9 | -171.9 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.6 | 32.6 | 21.8 | 23.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.6B SEK | 26 | 100.4 | -66.1 | -66.1 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.7 | 25.6 | 272.8 | |
| US |
|
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.9 | -50.8 | 46 | 461.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
